Form 4: Abeona Therapeutics Director Mark Alvino Sells 8,000 Shares
SEC Form 4 Filing
Director Mark Alvino of Abeona Therapeutics sold 8,000 shares of common stock on May 16, 2025, at an average price of $5.68.
Summary
- On May 16, 2025, Mark Alvino, a director of Abeona Therapeutics Inc. (ABEO), sold 8,000 shares of the company's common stock.
- The shares were sold at a weighted average price of $5.68.
- The sales occurred in multiple transactions with prices ranging from $5.63 to $5.77.
- Following the transaction, Alvino directly owns 92,435 shares of Abeona Therapeutics.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock sale by a company director. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment of interests.
Key Dates
| Date | Description |
|---|---|
| 05/16/2025 | Date of transaction: Mark Alvino sold 8,000 shares of Abeona Therapeutics. |
| 05/16/2025 | Date of report: Form 4 filing date. |
Keywords
Abeona Therapeutics, ABEO, Form 4, insider trading, Mark Alvino, stock sale, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.